Millions more could be exposed to the virus by 2018, the earliest a vaccine will be ready.
As cost overruns and delays plague the International Thermonuclear Experimental Reactor, fusion startups are raising more capital.
The first gene therapy approved in the Western world costs $1 million and has been used just once. The doctor who tried it says the price is “absolutely too high.”
Spider silk has the ability to resolve features smaller than any ordinary microscope can see, say materials scientists.
New software spots anomalies in modified or hacked cars.
Though politicians are increasingly willing to admit the planet is warming, they’re still reluctant to fund clean energy R&D.
AbbVie’s purchase of the cancer fighting startup backed by Peter Thiel’s Founders Fund bodes well for biotech funding.
Customized, printed orthopedic implants could be the future. In the meantime, the new manufacturing method is helping companies cut costs.
More nuclear plants could combat climate change, but safety concerns plague the industry—fairly or not.
State regulators have blocked several big transmission projects to bring wind power to the upper Midwest and the Southeast.